|
KR101261212B1
(ko)
|
2004-10-26 |
2013-05-07 |
돌비 레버러토리즈 라이쎈싱 코오포레이션 |
오디오 신호 처리 방법 및 장치
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
WO2009067493A2
(en)
*
|
2007-11-19 |
2009-05-28 |
Envivo Pharmaceuticals, Inc. |
1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
|
|
JP5099794B2
(ja)
|
2007-11-27 |
2012-12-19 |
アルデア バイオサイエンシーズ インク． |
新規化合物、組成物、及び使用方法
|
|
JP2011507909A
(ja)
|
2007-12-20 |
2011-03-10 |
エンビボ ファーマシューティカルズ インコーポレイテッド |
四置換ベンゼン
|
|
US8242154B2
(en)
|
2008-09-04 |
2012-08-14 |
Ardea Biosciences, Inc. |
Compounds, compositions and methods of using same for modulating uric acid levels
|
|
JP5620392B2
(ja)
*
|
2008-11-03 |
2014-11-05 |
タフツ ユニヴァーシティーＴｕｆｔｓ Ｕｎｉｖｅｒｓｉｔｙ |
クロストリジウム・ディフィシレ胞子の発芽および伸長を阻害するための方法および組成物
|
|
EP2255813A1
(en)
*
|
2009-05-29 |
2010-12-01 |
The Royal College of Surgeons in Ireland |
Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
|
|
ES2627682T3
(es)
|
2009-12-29 |
2017-07-31 |
Mapi Pharma Limited |
Compuestos intermedios y procesos para la preparación de tapentadol y compuestos relacionados
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
MX353408B
(es)
|
2010-04-22 |
2018-01-11 |
Vertex Pharma |
Proceso para producir compuestos de cicloalquilcarboxamido-indol.
|
|
AR081930A1
(es)
|
2010-06-16 |
2012-10-31 |
Ardea Biosciences Inc |
Compuestos de tioacetato
|
|
TWI499412B
(zh)
|
2010-06-16 |
2015-09-11 |
亞德生化公司 |
苯基硫乙酸酯組合物及其使用方法
|
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
|
WO2012120052A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8828995B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683705B1
(de)
|
2011-03-08 |
2015-04-22 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
MY180138A
(en)
|
2011-11-03 |
2020-11-23 |
Ardea Biosciences Inc |
3,4-di-substituted pyridine compound,methods of using and compositions comprising the same
|
|
BR112014027204A2
(pt)
|
2012-05-01 |
2017-06-27 |
Catabasis Pharmaceuticals Inc |
conjugados d ácido graxo de estatina e agonistas fxr; composições e método de usos
|
|
CN103665043B
(zh)
|
2012-08-30 |
2017-11-10 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药及其在医药上的应用
|
|
RU2650646C2
(ru)
|
2012-09-27 |
2018-04-16 |
Дзе Чилдрен'З Медикал Сентер Корпорейшн |
Соединения, предназначенные для лечения ожирения, и способы их применения
|
|
JP6422452B2
(ja)
*
|
2013-03-14 |
2018-11-14 |
ユニバーシティ オブ マカオＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｍａｃａｕ |
ヤクチ（益智（ａｌｐｉｎｉａｅｏｘｙｐｈｙｌｌａｅｆｒｕｃｔｕｓ））およびその全合成から単離される新規な抗神経変性天然化合物
|
|
RU2744460C2
(ru)
|
2014-04-15 |
2021-03-09 |
Вертекс Фармасьютикалз Инкорпорейтед |
Фармацевтические композиции для лечения заболеваний, опосредованных муковисцидозным трансмембранным регулятором проводимости
|
|
SG11201703717SA
(en)
*
|
2014-11-06 |
2017-06-29 |
Enanta Pharm Inc |
Bile acid analogs an fxr/tgr5 agonists and methods of use thereof
|
|
EP3223823A4
(en)
|
2014-11-26 |
2018-10-17 |
Enanta Pharmaceuticals, Inc. |
Bile acid analogs as fxr/tgr5 agonists and methods of use thereof
|
|
US10208081B2
(en)
|
2014-11-26 |
2019-02-19 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
|
|
US11578097B2
(en)
|
2014-11-26 |
2023-02-14 |
Enanta Pharmaceuticals, Inc. |
Tetrazole derivatives of bile acids as FXR/TGR5 agonists and methods of use thereof
|
|
EP3256134A4
(en)
|
2015-02-11 |
2018-10-03 |
Enanta Pharmaceuticals, Inc. |
Bile acid analogs as fxr/tgr5 agonists and methods of use thereof
|
|
WO2016161003A1
(en)
|
2015-03-31 |
2016-10-06 |
Enanta Phamraceuticals, Inc. |
Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
|
WO2017147159A1
(en)
|
2016-02-23 |
2017-08-31 |
Enanta Pharmaceuticals, Inc. |
Deuterated bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
|
|
WO2017147174A1
(en)
|
2016-02-23 |
2017-08-31 |
Enanta Pharmaceuticals, Inc. |
Heteroaryl containing bile acid analogs as fxr/tgr5 agonists and methods of use thereof
|
|
US10323060B2
(en)
|
2016-02-23 |
2019-06-18 |
Enanta Pharmaceuticals, Inc. |
Benzoic acid derivatives of bile acid as FXR/TGR5 agonists and methods of use thereof
|
|
DE102017005884A1
(de)
*
|
2016-07-07 |
2018-01-11 |
Merck Patent Gmbh |
Elektronisches Schaltelement
|
|
CN110121347A
(zh)
|
2016-11-29 |
2019-08-13 |
英安塔制药有限公司 |
制备磺酰脲胆汁酸衍生物的方法
|
|
US10472386B2
(en)
|
2017-02-14 |
2019-11-12 |
Enanta Pharmaceuticals, Inc. |
Bile acid derivatives as FXR agonists and methods of use thereof
|
|
BR112019020780A2
(pt)
|
2017-04-07 |
2020-04-28 |
Enanta Pharm Inc |
processo para preparação de derivados de ácido biliar de carbamato de sulfonila
|
|
DE102018004733A1
(de)
|
2018-06-14 |
2019-12-19 |
Merck Patent Gmbh |
Verfahren zur Herstellung eines elektronischen Bauteils enthaltend eine selbstorganisierte Monolage
|
|
CN116925168A
(zh)
|
2019-08-23 |
2023-10-24 |
深圳云合医药科技合伙企业(有限合伙) |
胆汁酸衍生物及其组合物和应用
|
|
EP4378946A4
(en)
*
|
2021-07-26 |
2025-07-30 |
Shaperon Inc |
NOVEL COMPOUND INHIBITING TNF-A GENERATION AND INFLAMMASOME ACTIVITY AND PREPARATION METHOD THEREOF
|